Ventures

07/02/2020

About Cleveland Clinic Ventures

Cleveland Clinic Ventures (CCV) places strategic investment into companies that address organizational priorities and healthcare white space opportunities for the resolution of large medical problems.

06/30/2020

NeuroTherapia

NeuroTherapia is a Cleveland-based company focused on discovering and developing new chemical entities for the treatment of neuroinflammation. NeuroTherapia’s lead product, NTRX-07, is a small orally-available molecule that targets specific receptors whose presence increase in certain conditions, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and chronic pain syndromes.

06/30/2020

Cleveland Diagnostics

Cleveland Diagnostics (CDx) is a Cleveland-based company dedicated to developing and commercializing biomarkers for the early detection of cancer, utilizing a first-in-class, patented, and proprietary technology – Solvent Interaction Analysis (SIA). SIA is a unique platform for the discovery and development of high-performance protein biomarkers that are structurally modified by molecular changes through the course of disease. Its initial focus is on prostate cancer with additional research efforts in markers for breast and ovarian cancer.

06/30/2020

Centerline Biomedical

Centerline Biomedical is a Cleveland-based company commercializing the Intra-Operative Positioning System (IOPS™) technology – an innovative, non-x-ray-based 3D surgical navigation solution that offers improved visualization within existing workflows. After years of hard work and dedication from vascular physicians and researchers at Cleveland Clinic, IOPS™ was born, with a working prototype and First-In-Human data.

06/30/2020

Cardionomic

Cardionomic is a Minneapolis-based company developing a transformative, minimally-invasive neuromodulation therapy addressing a large unmet need in the acute decompensated heart failure (ADHF) population. The company’s lead device is a catheter-based system used in a hospital setting to electrically stimulate selected nerves near the heart to improve its “squeeze” in heart failure patients.

06/30/2020

Autism Eyes

Autism Eyes is a Cleveland-based company formed in 2019 that is developing and validating a platform technology that enables physicians to accurately diagnose autism and its severity through observation of a patient’s eye movements in response to specific audiovisual stimuli.

Get In Touch With Us

Name

Ready to INVENT®? Download the Invention Disclosure Form Today.

Learn More

Save the Date for MIS2017: October 23-25 Genomics & Precision Medicine

Learn More